Abstract-The
In rabbit aorta, Furchgott and Zawadzki (1) reported that relaxation induced by acetylcholine is due to release of endothelium derived relaxing factor (EDRF). They sug gested that acetylcholine induces Ca influx into endothelial cells and the cellular Ca activates phospholipase A2, releases arachidonic acid from cell membrane, and EDRF is produced by lipoxygenase there from. Relaxation of vascular smooth muscle induced by histamine (2), 5-hydroxy tryptamine (3), bradykinin (4), adenosine (5) and nucleotides (6) seems to be also due to the same mechanism. In most of the vascular smooth muscles, norepinephrine is a potent stimulant which induces contraction mainly by increasing Ca influx (7, 8 Some of the experiments were repeated in rabbit aorta. A part of this work has been presented at the Japanese Phar macological Society Meeting (12).
Materials and Methods

Preparations:
Male Wistar rats, weighing about 200 g, were stunned and bled. The thoracic aorta was dissected out and strips, 2-3 mm wide and 5-8 mm long, were prepared.
Male New Zealand rabbits, weighing 2.0-2.5 kg, were killed by a rapid injection of sodium pentobarbital (25 mg/kg) and air into an ear vein. The thoracic aorta was rapidly removed and cut into helical strips, and muscle strips, 3-4 mm wide and 4-8 mm long, were prepared. Great care was taken not to injure the endothelium.
In some experiments, the endothelium was removed by gently rubbing the intimal surface with a finger moistened with physiological solution (1, 2, 6, 10, 11, (13) (14) (15) (16) .
Solutions: The normal bathing solution (pH 7.4, 37°C) contained 136.9 mM NaCl, 2.7 mM KCI, 1.5 mM CaCl2, 1.0 MM MgCl2, 23.8 mM NaHCO3 and 5.5 mM glucose. High K solution was made by hyperosmo tically adding 12 mM or 60 mM KCI to the above solution.
Tension recordings: Each strip was at tached to a holder under a resting tension of 1 g and equilibrated for 60 min in the bathing solution aerated with a 95%02 and 5% CO2 mixture.
The contractile tension of the muscle strip was recorded isometrically with a force-displacement transducer connected to a Nihon Kohden polygraph.
High K induced contraction was used for the standard because this contraction was not affected by the removal of the endothelium (see Results). Every preparation was checked to determine if carbachol induces a transient relaxation of norepinephrine-induced contraction in order to know the functional integrity of the endothelium. Results were expressed as the mean±S.E. of n experiments. Drugs: Drugs used in this experiment were I-norepinephrine bitartrate (Wako), carbamyl choline chloride (carbachol, Tokyo Kasei), quinacrine dihydrochloride (Sigma), me thylene blue trihydrate (Wako), tetraethyl ammonium chloride (TEA, Nakarai), angio tensin II (Hypertensin, Ciba-Geigy), indome thacin (Sigma), 2-(2,6-dichloroanilino)-2 imidazoline hydrochloride (clonidine, Tokyo Kasei), yohimbine hydrochloride (Sigma) and prazosin hydrochloride (Pfizer). (Table  1) . Further, 10-6 M carbachol did not relax the contraction induced by 60 mM K in rat aorta without endothelium and relaxed it only slightly (10.0±1.4%, n=6) in rat aorta with endothelium ( Fig. 1) . Therefore, we used the magnitude of 60 mM K-induced con traction as the reference. Addition of 10-6 M carbachol to the 10-7 M and 10-6 M norepinephrine-pretreated rat aorta with endothelium transiently relaxed the con traction by 69.2±2.4% (n=8) and 52.2±3.9% (n=10), respectively. In contrast, no relaxation was observed in rat aorta without endothelium (Fig. 1) . Concentration-response curves for norepinephrine in aortae with or without endothelium are shown in Fig. 2 . Maximum contractile tension induced by norepinephrine was enhanced (Figs. 1 and 2), and EC50 was decreased by removing endothelium in both rat and rabbit aortae (Table 2) . Inhibitory effect of carbachol on norepinephrine-induced contraction did not change after repeated applications of 60 mM K, suggesting that high K does not modify the function of endothelium. B. Effect of quinacrine, methylene blue, TEA and indomethacin:
As shown in Fig. 1 , 10-4 M quinacrine (added 10 min before and washed out on the application of nore pinephrine), 10-5 M methylene blue (added 60 min before) and 1 mM TEA (added 10 min before) inhibited the relaxation induced by 10-6 M carbachol in rat aorta with endo thelium. These agents also increased the magnitude of norepinephrine-induced con traction in rat aorta with endothelium: maxi mum contractile tension increased to 12'1.2% by quinacrine, to 137.7% by methylene blue and to 108.8% by TEA as shown in Table 3 . However, these agents did not or only slightly (in the case of quinacrine) potentiated the norepinephrine-induced contraction in rat aorta without endothelium (Table 3) . Also in rabbit aorta, methylene blue potentiated the 106 M norepinephrine-induced con traction to 127.3+1.4% (n=4). In contrast, 10-6 M indomethacin changed neither the norepinephrine-induced contraction nor the carbachol-induced relaxation in rat aorta with endothelium (P<0.05, n=6 each). C. Role of endothelium on clonidine induced contraction:
Clonidine in the con centrations of 10-9 M to 10-4 M did not induce contraction in rat aorta with endo thelium.
However, in the aorta without endothelium, clonidine induced a con traction with an EC50 of 2.92 x 10-7 M, and the maximum contraction induced by 3 x 10-6 M clonidine averaged 71.5+3.8% (n=11) of the 60 mM K-induced contraction. In methylene blue-pretreated aorta, clonidine also induced a contraction with a magnitude similar to that in the aorta without endo thelium. These contractions were not affected by carbachol. Hyperosomtic 60 mM K-induced contractile tension was taken as 100% in the ordinate.
Control: with endothelium, NE: norepinephrine, **: significantly different from control (P<0.01 ), n=4 each. D. Effects of yohimbine and prazosin: In rat aorta without endothelium, the sustained contraction induced by 10-6 M norepine phrine was inhibited by cumulative ap plications of prazosin with an IC50 (concen tration needed to induce 50% inhibition) of 8.55X10-9 M. Yohimbine in the concen trations of 10-9 M to 10-7 M did not show any effect on norepinephrine-induced con traction.
Higher concentrations of yohimbine inhibited the norepinephrine-induced con traction with an IC50 of 1.45X10-5 M. In rat aorta with endothelium, similar results were obtained, as shown in Table 4 .
The 3X10-6 M clonidine-induced con traction in the aorta without endothelium was inhibited by prazosin with an IC50 of 8.00X 10-9 M and also by higher concentrations of yohimbine with an IC50 of 9.5X10-6 M. Similar results were obtained in the aorta treated with methylene blue (Table 4) . Table 2 . EC50 (concentration needed to induce half maximum contraction) for norepinephrine Table  3 . Effects of quinacrine, methylene blue and TEA on 10-6 M norepinephrine-induced contraction in rat aorta with or without endothelium Table 4 . IC50 (concentration needed to induce a 50% inhibition) for yohimbine and prazosin in the contraction induced by either norepinephrine or clonidine in rat aorta E. Effects of clonidine on norepinephrine and angiotensin II-induced contractions: As shown in Fig. 3 , cumulative addition of clonidine during the 10-7 M norepinephrine induced contraction inhibited the muscle tension in the rat aorta with endothelium (IC50=2.05X10-7 M). Either removal of endothelium or pretreatment with methylene blue enhanced the norepinephrine-induced contraction and decreased the inhibitory effect of clonidine (IC50=2.26X10-6 M and 1 .82 x 10-6 M, respectively).
However, 10-7 M yohimbine did not change the inhibitory effect of clonidine ( Fig. 3 and Table 5 ).
ation. These contractions were inhibited by 10-6 M carbachol. A pretreatment with 10-7 M yohimbine did not modify the effect of clonidine (O).
Hov\./ever, removal of endothelium decreased the inhibitory effect of clonidine (o).
A pretreatment of the muscle with 10-5 M methylene blue had a similar effect to the endothelium removal (/).
Contractile tension before the application of clonidine was 84 .8% of the 60 mM K-induced contraction in the control (0) , 97.0% in yohimbine-treated aorta (0), 131.2% in the aorta without endothelium ([]) and 145.19`0 in the methylene blue-treated aorta significantly different from control with P<0.01 , n=4 to 8. The clonidine-induced contraction was greatly potentiated when endothelium was removed, as reported by Egleme et al. (10) . The clonidine-induced contraction was also potentiated by methylene blue-treatment. These results suggest that the contractile effect of clonidine is inhibited by EDRF. It has been known that clonidine is an agonist of a2-adrenoceptor and also a partial agonist of ai -adrenoceptor.
Clonidine inhibited the norepinephrine-induced contraction, as ex pected of a partial agonist (19). However, the result that the clonidine-induced in hibition was less in the absence of endothe lium or in the methylene blue-treated aorta suggests that the clonidine-induced relaxation is not solely due to a competition at the al adrenoceptor on the smooth muscle cells. These results suggest the possibility that clonidine releases EDRF from endothelium which may be mediated by the a2-adre noceptors on the endothelium, as suggested by Egleme et al. (10) .
To confirm this possibility, we used a relatively specific inhibitor of a2-adrenoceptor yohimbine (20) , and an inhibitor of al adrenoceptor, prazosin.
In the rat aorta without endothelium, the contractions induced by either norepinephrine or clonidine were similarly inhibited by prazosin and by higher concentrations of yohimbine, sug gesting that both norepinephrine and clonidine are acting on the same adrenoceptor possibly the al-subtype, on the smooth muscle cells (21). Assuming that the adrenoceptors on the endothelium are the a2-subtype, yohimbine is expected to inhibit the release of EDRF, but not the smooth muscle contraction induced by norepine phrine or clonidine and thus potentiates the contraction. However, this was not the case. Further, yohimbine did not affect the clonidine-induced relaxation in the aorta with endothelium.
From these results, it does not seem likely that norepinephrine and clonidine act on the a2-adrenoceptors on the endo thelium to release EDRF.
The fact that clonidine did not inhibit but rather potentiated the contraction induced by angiotensin II indicates that clonidine does not release EDRF. The reason why the inhibitory effect of clonidine on norepine phrine-induced contraction was weaker in the aorta without endothelium or in the methylene blue-treated aorta may be that the inhibitory effect of clonidine is partially overcome by its own contractile effect in the absence of spontaneous release of EDRF. Further, the inhibitory effect of EDRF on clonidine-induced contraction was at tenuated by angiotensin II and also by the membrane depolarization with 12 mM K or TEA. Removal of endothelium depolarizes the membrane of rat aorta by about 10 mV (Nishimura, A., Takewaki, Y. and Ohashi, H., personal communication) suggesting that the inhibitory effect of EDRF is at least partially mediated by a membrane hyperpolari zation.
From these results, it seems likely that the contractile effects of norepinephrine and clonidine are inhibited by the spontaneously released EDRF and that clonidine does not seem to have effects to stimulate the release of EDRF.
